Max Bayer – Page 7 – Endpoints News

about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Novo Nordisk claims late-stage MASH victory, continuing GLP-1's expansion

6 months ago

Compass Pathways delays key Phase 3 psilocybin readouts, spurring 30% layoffs

6 months ago

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

6 months ago

Updated: Pfizer’s Covid pill powers guidance raise, but shortfall elsewhere raises questions

6 months ago

BeiGene executive reportedly under investigation in China

6 months ago

Novartis pays Monte Rosa $150M for Phase 1 drug in latest endorsement of molecular glues

6 months ago

CDC advisors decline to recommend RSV shots to younger at-risk adults, affirming prior guidance

6 months ago

Icon's quarterly earnings hit by biotech and pharma pullback

6 months ago

Adults 50 and up should get pneumococcal vaccine, CDC advisors say, in boost to Pfizer and Merck

6 months ago

Pfizer wins approval to expand RSV vaccine to adults at higher infection risk

6 months ago

Starboard's Kenvue complaints are much different than those aimed at Pfizer

6 months ago

Updated: Pfizer's activist says board must 'hold management accountable' for R&D shortcomings

6 months ago

Starboard takes activist stake in J&J consumer spinout Kenvue

6 months ago

Vertex shares full pivotal non-opioid pain data, showing better safety than placebo

6 months ago

Lykos is optimistic about MDMA treatment after meeting with FDA

6 months ago

Pfizer’s RSV vaccine has 90% efficacy against severe respiratory disease

6 months ago

Bavarian Nordic's mpox vaccine was safe and spurred promising immune response in children

6 months ago

Facing a critical week, Pfizer confronts an unsparing foe in Starboard

6 months ago

J&J’s medtech slump continues, improvements not expected until 2025

6 months ago

J&J trims pipeline, including two mid-stage neuroscience studies

6 months ago

Sanofi lands on private equity firm CD&R as potential buyer of consumer health unit

7 months ago

Sanofi discontinues Denali-partnered MS trial after Phase 2 failure

7 months ago

Exclusive: How an accidental email tipped Pfizer off to an activist investor’s plan

7 months ago

Starboard launches first salvo in Pfizer fight, alleging ex-CEO, CFO were pressured to flip

7 months ago

First page Previous page 4 5 678 9 10 Next page Last page